Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Systemic lupus erythematosus as the concomitant manifestation of angioimmunoblastic T-cell lymphoma.

Suzuki A, Shoji N, Aoki N, Asazuma N, Machinami R, Kojima M, Okai T.

Mod Rheumatol. 2017 Mar;27(2):360-363. doi: 10.3109/14397595.2014.974880. Epub 2014 Nov 17.

PMID:
25401231
2.

"Possible primary antiphospholipid syndrome" with concurrent diffuse alveolar hemorrhaging and Libman-Sacks endocarditis mimicking catastrophic antiphospholipid syndrome.

Suzuki A, Asazuma N, Kikuchi E, Kawanobe T, Horimoto Y, Yokobari R, Kotake S, Okai T.

Intern Med. 2012;51(7):813-6. Epub 2012 Apr 1.

3.

[A very elderly case of complete remission by chemotherapy in a patient of primary esophageal non-Hodgkin lymphoma].

Yamashita H, Asazuma N, Nakamura H, Igarashi H, Machinami R, Ogata I.

Nihon Shokakibyo Gakkai Zasshi. 2012 Mar;109(3):400-7. Japanese.

PMID:
22398905
4.

Docking protein Gab2 positively regulates glycoprotein VI-mediated platelet activation.

Yi Q, Suzuki-Inoue K, Asazuma N, Inoue O, Watson SP, Ozaki Y.

Biochem Biophys Res Commun. 2005 Nov 18;337(2):446-51. Epub 2005 Sep 21.

PMID:
16198316
5.

Platelet GPIb-IX-V-dependent signaling.

Ozaki Y, Asazuma N, Suzuki-Inoue K, Berndt MC.

J Thromb Haemost. 2005 Aug;3(8):1745-51. Review.

6.

Cleavage of platelet endothelial cell adhesion molecule-1 (PECAM-1) in platelets exposed to high shear stress.

Naganuma Y, Satoh K, Yi Q, Asazuma N, Yatomi Y, Ozaki Y.

J Thromb Haemost. 2004 Nov;2(11):1998-2008.

7.
8.

Interaction between von Willebrand factor and glycoprotein Ib activates Src kinase in human platelets: role of phosphoinositide 3-kinase.

Wu Y, Asazuma N, Satoh K, Yatomi Y, Takafuta T, Berndt MC, Ozaki Y.

Blood. 2003 May 1;101(9):3469-76. Epub 2002 Aug 29.

9.

Differential role of glycolipid-enriched membrane domains in glycoprotein VI- and integrin-mediated phospholipase Cgamma2 regulation in platelets.

Wonerow P, Obergfell A, Wilde JI, Bobe R, Asazuma N, Brdicka T, Leo A, Schraven B, Horejsí V, Shattil SJ, Watson SP.

Biochem J. 2002 Jun 15;364(Pt 3):755-65.

10.

Glycoprotein IIb-IIIa-dependent aggregation by glycoprotein Ibalpha is reinforced by a Src family kinase inhibitor (PP1)-sensitive signalling pathway.

Marshall SJ, Asazuma N, Best D, Wonerow P, Salmon G, Andrews RK, Watson SP.

Biochem J. 2002 Jan 15;361(Pt 2):297-305.

11.
12.

C-terminal peptide of thrombospondin-1 induces platelet aggregation through the Fc receptor gamma-chain-associated signaling pathway and by agglutination.

Tulasne D, Judd BA, Johansen M, Asazuma N, Best D, Brown EJ, Kahn M, Koretzky GA, Watson SP.

Blood. 2001 Dec 1;98(12):3346-52.

13.

The role of ITAM- and ITIM-coupled receptors in platelet activation by collagen.

Watson SP, Asazuma N, Atkinson B, Berlanga O, Best D, Bobe R, Jarvis G, Marshall S, Snell D, Stafford M, Tulasne D, Wilde J, Wonerow P, Frampton J.

Thromb Haemost. 2001 Jul;86(1):276-88. Review.

PMID:
11487016
14.

The snake venom toxin alboaggregin-A activates glycoprotein VI.

Asazuma N, Marshall SJ, Berlanga O, Snell D, Poole AW, Berndt MC, Andrews RK, Watson SP.

Blood. 2001 Jun 15;97(12):3989-91.

15.

Role of Fc receptor gamma-chain in platelet glycoprotein Ib-mediated signaling.

Wu Y, Suzuki-Inoue K, Satoh K, Asazuma N, Yatomi Y, Berndt MC, Ozaki Y.

Blood. 2001 Jun 15;97(12):3836-45.

16.

A novel viper venom metalloproteinase, alborhagin, is an agonist at the platelet collagen receptor GPVI.

Andrews RK, Gardiner EE, Asazuma N, Berlanga O, Tulasne D, Nieswandt B, Smith AI, Berndt MC, Watson SP.

J Biol Chem. 2001 Jul 27;276(30):28092-7. Epub 2001 May 8.

17.

Interaction of linker for activation of T cells with multiple adapter proteins in platelets activated by the glycoprotein VI-selective ligand, convulxin.

Asazuma N, Wilde JI, Berlanga O, Leduc M, Leo A, Schweighoffer E, Tybulewicz V, Bon C, Liu SK, McGlade CJ, Schraven B, Watson SP.

J Biol Chem. 2000 Oct 27;275(43):33427-34.

18.

Activation of protein-tyrosine kinase pathways in human platelets stimulated with the A1 domain of von Willebrand factor.

Satoh K, Asazuma N, Yatomi Y, Fujimura Y, Miura S, Titani K, Ozaki Y.

Platelets. 2000 May;11(3):171-6.

PMID:
10938894
19.

Platelet activation mediated through membrane glycoproteins: involvement of tyrosine kinases.

Ozaki Y, Qi R, Satoh K, Asazuma N, Yatomi Y.

Semin Thromb Hemost. 2000;26(1):47-51. Review.

PMID:
10805282
21.

LAT is required for tyrosine phosphorylation of phospholipase cgamma2 and platelet activation by the collagen receptor GPVI.

Pasquet JM, Gross B, Quek L, Asazuma N, Zhang W, Sommers CL, Schweighoffer E, Tybulewicz V, Judd B, Lee JR, Koretzky G, Love PE, Samelson LE, Watson SP.

Mol Cell Biol. 1999 Dec;19(12):8326-34.

22.

FcgammaRII tyrosine phosphorylation differs between FcgammaRII cross-linking and platelet-activating anti-platelet monoclonal antibodies.

Qi R, Ozaki Y, Asazuma N, Satoh K, Yatomi Y, Law CL, Hato T, Nomura S.

Biochim Biophys Acta. 1999 Sep 21;1451(2-3):353-63.

24.

Glycoprotein Ib-von Willebrand factor interactions activate tyrosine kinases in human platelets.

Asazuma N, Ozaki Y, Satoh K, Yatomi Y, Handa M, Fujimura Y, Miura S, Kume S.

Blood. 1997 Dec 15;90(12):4789-98.

25.

Sphingosine 1-phosphate, a bioactive sphingolipid abundantly stored in platelets, is a normal constituent of human plasma and serum.

Yatomi Y, Igarashi Y, Yang L, Hisano N, Qi R, Asazuma N, Satoh K, Ozaki Y, Kume S.

J Biochem. 1997 May;121(5):969-73.

26.

Tyrosine phosphorylation and p72syk activation by an anti-glycoprotein Ib monoclonal antibody.

Yanabu M, Ozaki Y, Nomura S, Miyake T, Miyazaki Y, Kagawa H, Yamanaka Y, Asazuma N, Satoh K, Kume S, Komiyama Y, Fukuhara S.

Blood. 1997 Mar 1;89(5):1590-8.

27.

Differential activation of human platelets induced by Fc gamma receptor II cross-linking and by anti-CD9 monoclonal antibody.

Qi R, Ozaki Y, Kuroda K, Asazuma N, Yatomi Y, Satoh K, Nomura S, Kume S.

J Immunol. 1996 Dec 15;157(12):5638-45.

PMID:
8955216
28.

Activation of protein-tyrosine kinase Syk in human platelets stimulated with lysophosphatidic acid or sphingosine 1-phosphate.

Yang L, Yatomi Y, Hisano N, Qi R, Asazuma N, Satoh K, Igarashi Y, Ozaki Y, Kume S.

Biochem Biophys Res Commun. 1996 Dec 13;229(2):440-4.

PMID:
8954916
29.

Differential mobilization of tyrosine kinases in human platelets stimulated with thrombin or thrombin receptor agonist peptide.

Satoh K, Ozaki Y, Asazuma N, Yatomi Y, Ruomei Q, Kuroda K, Yang L, Kume S.

Biochem Biophys Res Commun. 1996 Aug 23;225(3):1084-9.

PMID:
8780738
30.

Intracellular levels of cyclic AMP and cyclic GMP differentially modify platelet aggregate size in human platelets activated with epinephrine or ADP.

Qi R, Ozaki Y, Satoh K, Yang LB, Asazuma N, Yatomi Y, Kume S.

J Cardiovasc Pharmacol. 1996 Aug;28(2):215-22.

PMID:
8856476
31.
32.
33.

Quantitative measurement of various 5-HT receptor antagonists on platelet activation induced by serotonin.

Qi R, Ozaki Y, Satoh K, Kurota K, Asazuma N, Yatomi Y, Kume S.

Thromb Res. 1996 Jan 1;81(1):43-54.

PMID:
8747519
34.

Fc gamma II receptor-mediated platelet activation induced by anti-CD9 monoclonal antibody opens Ca2+ channels which are distinct from those associated with Ca2+ store depletion.

Kuroda K, Ozaki Y, Qi R, Asazuma N, Yatomi Y, Satoh K, Nomura S, Suzuki M, Kume S.

J Immunol. 1995 Nov 1;155(9):4427-36.

PMID:
7594604
35.

Sulphonylurea agents inhibit platelet aggregation and [Ca2+]i elevation induced by arachidonic acid.

Qi R, Ozaki Y, Satoh K, Kurota K, Asazuma N, Yatomi Y, Kume S.

Biochem Pharmacol. 1995 Jun 16;49(12):1735-9.

PMID:
7598735

Supplemental Content

Loading ...
Support Center